Dupont Capital Management Corp Harvard Bioscience Inc Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$3.28 - $6.42 $78,670 - $153,983
-23,985 Closed
0 $0
Q1 2022

Apr 27, 2022
SELL
$5.16 - $7.14 $10,949 - $15,151
-2,122 Reduced 8.13%
23,985 $149,000
Q4 2021

Jan 31, 2022
SELL
$6.37 - $8.18 $66,305 - $85,145
-10,409 Reduced 28.51%
26,107 $184,000
Q3 2021

Nov 03, 2021
SELL
$6.98 - $8.47 $36,030 - $43,722
-5,162 Reduced 12.39%
36,516 $255,000
Q2 2021

Jul 30, 2021
BUY
$5.44 - $8.4 $226,728 - $350,095
41,678 New
41,678 $347,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email